ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
-20.31%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$116M
AUM Growth
+$116M
(-53%)
Cap. Flow
-$74.4M
Cap. Flow
% of AUM
-64%
Top 10 Holdings %
Top 10 Hldgs %
87.62%
Holding
29
New
2
Increased
7
Reduced
6
Closed
7
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$7.05M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$4.99M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.03M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$872K |
| 5 |
ACER
Acer Therapeutics Inc. Common Stock (DE)
ACER
|
$679K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$23.6M |
| 2 |
Arrowhead Research
ARWR
|
$14.9M |
| 3 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
$9.3M |
| 4 |
Veracyte
VCYT
|
$8.18M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$7.07M |
Sector Composition
| 1 | Healthcare | 93.46% |